These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 9222274)
21. The evolution and origin of motor complications in Parkinson's disease. Obeso JA; Rodriguez-Oroz MC; Chana P; Lera G; Rodriguez M; Olanow CW Neurology; 2000; 55(11 Suppl 4):S13-20; discussion S21-3. PubMed ID: 11147505 [TBL] [Abstract][Full Text] [Related]
22. Parkinson's disease: diagnosis and treatment. Rao SS; Hofmann LA; Shakil A Am Fam Physician; 2006 Dec; 74(12):2046-54. PubMed ID: 17186710 [TBL] [Abstract][Full Text] [Related]
23. Management of Parkinson's disease a review of current and new therapies. Mendis T; Suchowersky O; Lang A; Gauthier S Can J Neurol Sci; 1999 May; 26(2):89-103. PubMed ID: 10352867 [TBL] [Abstract][Full Text] [Related]
32. When time is of the essence: Managing care in emergency situations in Parkinson's disease. Prasad S; Pal PK Parkinsonism Relat Disord; 2019 Feb; 59():49-56. PubMed ID: 30253924 [TBL] [Abstract][Full Text] [Related]
33. Treatment of motor fluctuations in Parkinson's disease: recent developments and future directions. Ramirez-Zamora A; Molho E Expert Rev Neurother; 2014 Jan; 14(1):93-103. PubMed ID: 24328720 [TBL] [Abstract][Full Text] [Related]
34. [Cognitive and neuropsychiatric disorders in Parkinson's disease]. Rodríguez-Constenla I; Cabo-López I; Bellas-Lamas P; Cebrián E Rev Neurol; 2010 Feb; 50 Suppl 2():S33-9. PubMed ID: 20205140 [TBL] [Abstract][Full Text] [Related]
35. An open-label evaluation of the tolerability and safety of Stalevo (carbidopa, levodopa and entacapone) in Parkinson's disease patients experiencing wearing-off. Koller W; Guarnieri M; Hubble J; Rabinowicz AL; Silver D J Neural Transm (Vienna); 2005 Feb; 112(2):221-30. PubMed ID: 15503197 [TBL] [Abstract][Full Text] [Related]
36. Motor complications in Parkinson's disease. Ondo WG Int J Neurosci; 2011; 121 Suppl 2():37-44. PubMed ID: 22035028 [TBL] [Abstract][Full Text] [Related]
37. Does levodopa slow or hasten the rate of progression of Parkinson's disease? Fahn S; J Neurol; 2005 Oct; 252 Suppl 4():IV37-IV42. PubMed ID: 16222436 [TBL] [Abstract][Full Text] [Related]